NEW YORK (TheStreet) -- Vitamin Shoppe (VSI) - Get Report stock is declining 13.51% to $26.89 on heavy trading volume on Tuesday afternoon after the Secaucus, NJ-based company delivered lower than expected revenue for the fiscal 2015 fourth quarter.

Before today's market open, the specialty retailer and nutritional products manufacturer reported revenue of $293.49 million for the quarter ended December 26, missing estimates of $294.06 million.

Quarterly adjusted earnings of 39 cents per diluted share surpassed estimates by 1 cent.

Revenue increased 1.2% year-over-year, with a 3.9% rise in e-commerce sales offsetting a 0.9% drop in comparable retail store sales for the quarter.

"We are disappointed with top line performance as industry headwinds and lack of new product innovation impacted comparable sales which, in turn, did not meet our expectations," CEO Colin Watts said in a statement.

So far today, 1.39 million shares of Vitamin Shoppe have exchanged hands, compared with its average daily volume of 405,557 shares.

TheStreet Recommends

Separately, Vitamin Shoppe has a "hold" rating and a letter grade of C at TheStreet Ratings because of the company's strengths, such as increase in net income, revenue growth and reasonable valuation levels, and its weaknesses, including disappointing return on equity, weak operating cash flow and generally disappointing stock performance.

You can view the full analysis from the report here: VSI

TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

Image placeholder title


data by